Number of the records: 1
Dendritic cell-based immunotherapy (DCVAC/OvCa) withchemotherapy in patients with platinum-sensitive, relapsed,epithelial ovarian carcinoma: Survival analysis of a phase II,open-label, randomized, multicenter trial (study SOV02)
- 1.0506303 - ÚI 2020 US eng A - Abstract
Cibula, D. - Rob, L. - Mallmann, P. - Knapp, P. - Bartůňková, J. - Spíšek, R. - Hassan, H. I. - Pecen, Ladislav - Klat, J. - Chovanec, J.
Dendritic cell-based immunotherapy (DCVAC/OvCa) withchemotherapy in patients with platinum-sensitive, relapsed,epithelial ovarian carcinoma: Survival analysis of a phase II,open-label, randomized, multicenter trial (study SOV02).
Gynecologic Oncology. Elsevier. Roč. 154, suppl. 1 (2019), s. 18-18. ISSN 0090-8258. E-ISSN 1095-6859.
[Annual Meeting of the Society of Gynecologic Oncology /50./. 16.03.2019-19.03.2019, Honolulu]
Institutional support: RVO:67985807
Permanent Link: http://hdl.handle.net/11104/0297589
Number of the records: 1